Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

UWC reported for 6 months of 2023 under IFRS

9/5/23 UWGN

Medsi intends to enter markets in other countries

9/5/23 AFKS

SPB Exchange summarized the results of trading in August

9/5/23 SPBE

Moscow Exchange summarized the results of trading in August

9/4/23 MOEX

Number of investors has reached 34% of economically active population

9/4/23 MOEX

Rosseti started an additional share issue to acquire regional assets

9/4/23 FEES

VK Video platform is out of beta version

9/4/23 VKCO

Magnit opened the first kiosk GO at the railway station

9/4/23 MGNT

MTS bought the ticketing service Ticketscloud

9/4/23 MTSS

Alrosa started construction of Mir-Gluboky mine

9/4/23 ALRS